Latest Breaking News On - Ocally advanced or metastatic breast cancer - Page 1 : comparemela.com

The FDA has issued a complete response letter to the biologics license application for vic-trastuzumab duocarmazine for the treatment of patients with HER2-positive unresectable, locally advanced or metastatic breast cancer.

United kingdomSaura manichMarco timmersEuropean unionDrug administrationFda has issueda complete response letterBiologics license application for vic trastuzumab duocarmazineHer2 positive unresectableOcally advanced or metastatic breast cancerPhase 3 tulip trial